Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Nov 29;44(4):86.
doi: 10.1007/s10555-025-10301-2.

Advancing small cell lung cancer metastasis research: innovations in preclinical mouse models

Qiqi Zhao  1   2   3 , Liang Hu  4   5 , Hongbin Ji  6   7   8   9   10
Affiliations
Review

Advancing small cell lung cancer metastasis research: innovations in preclinical mouse models

Qiqi Zhao et al. Cancer Metastasis Rev. .

Abstract

Small cell lung cancer (SCLC) represents one of the most aggressive malignancies, featured with its extraordinary metastatic capacity. Preclinical mouse models have become indispensable systems for studying the molecular mechanisms underlying SCLC metastasis. This review summarizes recent advances in genetically engineered mouse models (GEMMs) and transplantation models for SCLC metastasis research, highlighting their unique advantages in investigating oncogenic drivers, tumor heterogeneity, immune interactions, and therapeutic responses. We further discuss emerging technologies capable of integrating with these models to advance both mechanistic and translational research. Lineage tracing and multi-omics approaches have provided unprecedented resolution in mapping clonal dynamics and phenotypic plasticity during SCLC metastasis. High-throughput in vivo screening has accelerated the systematic identification of novel metastasis regulators, and humanized mouse models offer clinically relevant systems for investigating human-specific tumor-immune interactions and supporting preclinical evaluation of immunotherapies. Collectively, these preclinical systems are reshaping our understanding of SCLC metastasis and providing powerful platforms to guide therapeutic discovery.

Keywords: Allografts; Genetically engineered mouse models; Mouse models; Small cell lung cancer metastasis; Xenografts.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interest: The authors declare no competing interests.

References

    1. Rudin, C. M., Brambilla, E., Faivre-Finn, C., & Sage, J. (2021). Small-cell lung cancer. Nature Reviews Disease Primers, 7(1), 3. https://doi.org/10.1038/s41572-020-00235-0 - DOI - PubMed - PMC
    1. Megyesfalvi, Z., Gay, C. M., Popper, H., Pirker, R., Ostoros, G., Heeke, S., Lang, C., Hoetzenecker, K., Schwendenwein, A., Boettiger, K., Bunn, P. A., Jr., Renyi‐Vamos, F., Schelch, K., Prosch, H., Byers, L. A., Hirsch, F. R., & Dome, B. (2023). Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/caac.21785 - DOI - PubMed
    1. Gazdar, A. F., Bunn, P. A., & Minna, J. D. (2017). Small-cell lung cancer: What we know, what we need to know and the path forward. Nature Reviews Cancer, 17(12), 725–737. https://doi.org/10.1038/nrc.2017.87 - DOI - PubMed
    1. Meuwissen, R., Linn, S. C., Linnoila, R. I., Zevenhoven, J., Mooi, W. J., & Berns, A. (2003). Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell, 4(3), 181–189. https://doi.org/10.1016/S1535-6108(03)00220-4 - DOI - PubMed
    1. Semenova, E. A., Nagel, R., & Berns, A. (2015). Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes & Development, 29(14), 1447–1462. https://doi.org/10.1101/gad.263145.115 - DOI

LinkOut - more resources